Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Zanthoxylum Americanum Bark is a specialized botanical substance primarily utilized as a non-standardized allergenic extract for diagnostic testing and immunotherapy. It is also classified within several pharmacological categories including nitrogen binding agents and adrenergic agonists.
Name
Zanthoxylum Americanum Bark
Raw Name
ZANTHOXYLUM AMERICANUM BARK
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
30
Variant Count
41
Last Verified
February 17, 2026
About Zanthoxylum Americanum Bark
Zanthoxylum Americanum Bark is a specialized botanical substance primarily utilized as a non-standardized allergenic extract for diagnostic testing and immunotherapy. It is also classified within several pharmacological categories including nitrogen binding agents and adrenergic agonists.
Detailed information about Zanthoxylum Americanum Bark
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Zanthoxylum Americanum Bark.
Zanthoxylum Americanum Bark, commonly known as Northern Prickly Ash or the 'Toothache Tree,' is a botanical substance derived from the dried bark of the Zanthoxylum americanum Mill. plant, a member of the Rutaceae family. In the modern clinical landscape, Zanthoxylum Americanum Bark belongs to a class of drugs primarily called Non-Standardized Plant Allergenic Extracts. However, due to its complex chemical profile, regulatory bodies also categorize it under diverse pharmacological classes including Nitrogen Binding Agents, Pediculicides, and even as having properties related to Adrenocorticotropic Hormone (ACTH) and Adrenergic Agonists.
Historically, the bark has been used in traditional medicine for its numbing properties (hence the name 'Toothache Tree'). In contemporary medicine, its most significant FDA-recognized role is as an allergenic extract. These extracts are used by allergists and immunologists to diagnose specific sensitivities through skin testing and to treat those sensitivities via allergen immunotherapy (allergy shots). The FDA regulates these extracts under the Center for Biologics Evaluation and Research (CBER), ensuring that while they are 'non-standardized' (meaning they lack a fixed potency unit compared to a reference standard), they are manufactured under strict Good Manufacturing Practices (GMP).
The mechanism of action for Zanthoxylum Americanum Bark varies significantly depending on its clinical application. When used as an Allergenic Extract, it works by interacting with the patient's immune system. Upon exposure during skin testing, the proteins and antigens within the bark extract bind to specific Immunoglobulin E (IgE) antibodies on the surface of mast cells and basophils. If a patient is sensitized, this binding triggers the release of inflammatory mediators like histamine, resulting in a localized 'wheal and flare' reaction, which confirms the allergy.
At a molecular level, the bark contains a rich array of alkaloids, including chelerythrine, nitidine, and berberine. These compounds contribute to its classification as a Nitrogen Binding Agent and Adrenergic Agonist. Research suggests that these alkaloids can interact with alpha and beta-adrenergic receptors, potentially modulating sympathetic nervous system responses. Furthermore, its role as a nitrogen-binding agent involves the sequestration of ammonium ions, which is a critical pathway in managing certain metabolic imbalances. The presence of coumarins and resins also contributes to its pharmacodynamic profile, influencing vascular permeability and local anesthetic-like effects.
The pharmacokinetics of Zanthoxylum Americanum Bark are complex because it is a multi-component botanical extract rather than a single molecular entity.
The primary FDA-approved clinical indications for Zanthoxylum Americanum Bark extracts include:
Zanthoxylum Americanum Bark is available in several specialized forms:
> Important: Only your healthcare provider can determine if Zanthoxylum Americanum Bark is right for your specific condition. Because it is a potent allergen, administration must occur under medical supervision.
Dosage for Zanthoxylum Americanum Bark varies critically based on whether it is being used for diagnosis or treatment.
Zanthoxylum Americanum Bark extracts are used in children, but with extreme caution.
There are no specific dose adjustment guidelines for renal impairment regarding allergenic extracts; however, patients with compromised kidney function may be at higher risk for complications if a systemic reaction occurs. Use with caution.
Because the alkaloids in Zanthoxylum Americanum Bark are metabolized by the liver, patients with severe hepatic impairment (Child-Pugh Class C) should be monitored closely for potential toxicity if using oral forms of the bark.
Elderly patients often have a higher prevalence of cardiovascular disease. Since the treatment for a reaction to the bark (epinephrine) can stress the heart, the benefit-risk ratio must be carefully evaluated in patients over 65.
For clinical allergenic extracts:
For oral/supplemental forms:
If a dose of immunotherapy is missed:
An overdose of Zanthoxylum Americanum Bark extract typically manifests as a severe systemic allergic reaction or anaphylaxis. Signs include:
Emergency Measures: In the event of an overdose or systemic reaction, epinephrine (0.3 mg for adults) must be administered immediately, followed by emergency medical transport to a hospital.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
Most patients receiving Zanthoxylum Americanum Bark extracts will experience localized reactions at the site of administration. These are generally expected and include:
> Warning: Stop taking Zanthoxylum Americanum Bark and call your doctor immediately if you experience any of these.
Prolonged use of Zanthoxylum Americanum Bark in high doses (especially oral supplements) may lead to:
While Zanthoxylum Americanum Bark as a single ingredient may not have a specific individual black box warning, the class of Allergenic Extracts carries a general warning regarding the risk of severe non-fatal and fatal systemic reactions.
FDA Class Warning Summary: Allergenic extracts should only be administered by physicians who are exceptionally experienced in the treatment of systemic reactions and have the necessary equipment (epinephrine, oxygen, IV fluids) available. Patients with unstable asthma are at a significantly higher risk for fatal reactions and must be evaluated with extreme caution.
Report any unusual symptoms to your healthcare provider.
Zanthoxylum Americanum Bark is a potent biological substance. It must never be self-administered if it is in the form of an allergenic extract. Patients must be screened for recent illnesses, as receiving an extract while the immune system is already stressed (e.g., during a viral infection) can increase the risk of a systemic reaction. Furthermore, patients should avoid vigorous exercise for at least two hours before and after receiving an injection, as increased circulation can accelerate the absorption of the allergen.
No specific FDA black box warning exists solely for 'Zanthoxylum Americanum Bark' as a standalone chemical entity; however, it falls under the mandatory class warnings for Allergenic Extracts. This warning emphasizes that these products can cause severe, life-threatening anaphylaxis. It mandates that administration occurs in a clinical setting with at least a 30-minute post-injection observation period.
For patients undergoing long-term immunotherapy or high-dose supplemental use, the following monitoring is recommended:
Generally, Zanthoxylum Americanum Bark does not cause sedation. However, if a patient experiences a systemic reaction or receives epinephrine, they should not drive or operate machinery until they have fully recovered and been cleared by a medical professional.
Alcohol should be avoided on the day of an allergenic extract injection. Alcohol can cause vasodilation (widening of blood vessels), which may increase the rate of extract absorption and potentially worsen an allergic reaction.
If Zanthoxylum Americanum Bark is being used for immunotherapy, stopping abruptly will result in a loss of the desensitization effect. If it must be stopped due to a severe reaction, the physician will determine if and how to restart the therapy safely. There is no 'withdrawal syndrome' associated with this substance, but the return of original allergy symptoms is likely.
> Important: Discuss all your medical conditions with your healthcare provider before starting Zanthoxylum Americanum Bark.
For each major interaction, the mechanism involves either pharmacodynamic interference (e.g., beta-blockers blocking epinephrine) or pharmacokinetic alteration (e.g., CYP induction). The clinical consequence is often an increased risk of untreatable anaphylaxis or reduced diagnostic accuracy. Management involves pausing interfering medications or adjusting the extract dose under strict supervision.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Zanthoxylum Americanum Bark must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
Patients who are allergic to other members of the Rutaceae family (including lemons, oranges, grapefruit, and Rue) may exhibit cross-sensitivity to Zanthoxylum Americanum Bark. This occurs because of shared protein structures (homologous allergens) across the genus. If you have a known severe allergy to citrus, you must inform your allergist before testing with Prickly Ash bark.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Zanthoxylum Americanum Bark.
FDA Pregnancy Category C. There are no adequate and well-controlled studies of Zanthoxylum Americanum Bark in pregnant women.
It is not known whether the components of Zanthoxylum Americanum Bark are excreted in human milk. Because many alkaloids are lipid-soluble, there is a theoretical possibility of transfer. However, the small amounts used in allergenic extracts are unlikely to reach significant concentrations in breast milk. Risk-benefit considerations should prioritize the mother's allergic stability while monitoring the infant for any unusual rashes or digestive changes.
Patients over age 65 may have a higher risk of complications.
While no specific dose adjustments are mandated for the extract form, the nitrogen-binding properties of the bark may interact with the metabolic state of patients with chronic kidney disease (CKD). Patients on dialysis should be monitored for changes in electrolyte or ammonium balance if using oral forms of the bark.
In patients with significant liver dysfunction, the metabolism of isoquinoline alkaloids found in the bark may be delayed. This could lead to an accumulation of these compounds, potentially causing increased side effects such as nausea, dizziness, or palpitations. Use with caution in Child-Pugh Class B or C patients.
> Important: Special populations require individualized medical assessment.
Zanthoxylum Americanum Bark acts through multiple pathways. As an Allergenic Extract, it facilitates the cross-linking of IgE receptors on mast cells, leading to degranulation. On a pharmacological level, its alkaloids (specifically chelerythrine and nitidine) act as potent inhibitors of certain enzymes and may function as Adrenergic alpha and beta agonists. This means they can mimic the effects of the sympathetic nervous system, affecting heart rate and vascular tone. Additionally, its classification as a Nitrogen Binding Agent stems from the ability of its chemical constituents to react with and neutralize ammonium ions, which is a mechanism explored in metabolic research.
| Parameter | Value |
|---|---|
| Bioavailability | Low (Subcutaneous); Variable (Oral) |
| Protein Binding | 70-85% (for primary alkaloids) |
| Half-life | 2-6 hours |
| Tmax | 1-2 hours (Oral) |
| Metabolism | Hepatic (CYP3A4/2D6) |
| Excretion | Renal (approx. 60%), Fecal (approx. 40%) |
Zanthoxylum Americanum Bark is categorized as a Non-Standardized Plant Allergenic Extract. It is related to other extracts in the Rutaceae family and shares pharmacological space with other nitrogen-binding agents used in metabolic medicine.
Medications containing this ingredient
Common questions about Zanthoxylum Americanum Bark
Zanthoxylum Americanum Bark is primarily used in clinical medicine as an allergenic extract for the diagnosis and treatment of specific allergies. Allergists use it in skin prick tests to determine if a patient is sensitive to the proteins found in the Northern Prickly Ash tree. If an allergy is confirmed, it can be used in immunotherapy, also known as allergy shots, to help the body build a tolerance to the allergen over time. Beyond its use in allergy, it has historical applications for relieving dental pain due to its natural numbing properties. It is also classified as a nitrogen-binding agent, which means it may play a role in managing certain chemical imbalances in the body. Always consult a specialist to see if this treatment is appropriate for your specific health needs.
The most frequent side effects associated with Zanthoxylum Americanum Bark are localized reactions at the site of the injection or skin test. These typically include redness, swelling, and itching that appear shortly after the extract is administered. Some patients may also experience a 'large local reaction' where the swelling spreads several inches across the skin. If the bark is taken in oral or supplemental forms, it often causes a characteristic tingling or 'prickly' sensation in the mouth and throat. Other less common effects include mild fatigue, headache, or slight nausea. While these are usually not dangerous, they should be reported to your healthcare provider to ensure your dosage is correct.
It is strongly advised to avoid alcohol consumption on the days you receive a Zanthoxylum Americanum Bark injection. Alcohol acts as a vasodilator, which means it widens your blood vessels and increases blood flow throughout the body. This increased circulation can cause the allergenic extract to be absorbed into your system more quickly than intended, which significantly raises the risk of a severe systemic allergic reaction. Furthermore, alcohol can interfere with your body's ability to respond to emergency medications if a reaction does occur. To ensure your safety during immunotherapy, it is best to refrain from drinking for at least 24 hours around your appointment. Always discuss your lifestyle habits with your allergist before starting treatment.
The safety of Zanthoxylum Americanum Bark during pregnancy has not been fully established, and it is classified by the FDA as Pregnancy Category C. Most medical professionals recommend against starting new immunotherapy or diagnostic testing with this extract while pregnant because of the risk of anaphylaxis. A severe allergic reaction can lead to a drop in blood pressure and oxygen levels, which can be dangerous for the developing fetus. However, if a patient is already on a stable maintenance dose of allergy shots and becomes pregnant, many doctors will continue the treatment at that same dose. The decision to continue or stop must be made on an individual basis by weighing the risks of the allergy against the risks of the treatment. Talk to your obstetrician and allergist for personalized guidance.
The timeframe for Zanthoxylum Americanum Bark to work depends on the intended use. For diagnostic purposes, such as a skin prick test, the results are almost immediate, usually appearing within 15 to 20 minutes. However, when used as a treatment in the form of allergy shots (immunotherapy), the process is much slower. Most patients will not notice a significant reduction in their allergy symptoms until they reach their 'maintenance dose,' which typically takes 3 to 6 months of weekly injections. Full effectiveness and long-term relief often require consistent treatment for 1 to 3 years. It is important to have realistic expectations and stay consistent with your appointment schedule to see the best results.
Stopping Zanthoxylum Americanum Bark immunotherapy suddenly does not cause a physical withdrawal syndrome like some other medications, but it will likely cause your allergy symptoms to return. The goal of the treatment is to slowly retrain your immune system, and this progress is lost if the injections are discontinued prematurely. If you stop for more than a few weeks and then try to restart, you may be at a higher risk for a reaction because your body's tolerance has dropped. If you need to stop treatment due to side effects or life changes, you should do so under the guidance of your doctor. They can help you determine the safest way to taper off or restart the therapy in the future.
If you miss a dose of your Zanthoxylum Americanum Bark injection, you should contact your allergist's office as soon as possible to reschedule. The safety of the next dose depends on how much time has passed since your last injection. If you are only a few days late, you can usually proceed with your regular dose. However, if you have missed several weeks, your doctor may need to reduce the dose for your next visit to prevent an allergic reaction. Missing too many doses may require you to go back several steps in your 'build-up' phase. Never try to 'double up' on doses to make up for a missed one, as this significantly increases the risk of anaphylaxis.
There is currently no clinical evidence to suggest that Zanthoxylum Americanum Bark causes weight gain. Unlike some other treatments for allergies, such as systemic oral steroids (like prednisone), allergenic extracts do not interfere with the metabolic processes that typically lead to weight changes. The alkaloids found in the bark, such as chelerythrine, are not associated with increased appetite or fat storage. If you notice unexpected weight changes while undergoing treatment, it is likely due to other factors or medications. You should discuss any significant changes in your weight or health with your primary care physician to rule out other underlying causes.
Zanthoxylum Americanum Bark can interact with several other medications, some of which are very serious. The most critical interaction is with beta-blockers, which are often used for heart disease or high blood pressure; these can make a serious allergic reaction much harder to treat. Other medications like ACE inhibitors and certain antidepressants can also increase the risk of a severe reaction. Additionally, taking antihistamines can hide the early signs of an allergy shot reaction, which might be dangerous. It is vital that you provide your healthcare provider with a complete list of all prescription drugs, over-the-counter medicines, and herbal supplements you are taking. This allows them to adjust your treatment plan for maximum safety.
Zanthoxylum Americanum Bark is not sold as a 'generic' in the way that standard pills like ibuprofen are. Instead, it is produced by several different specialized laboratories as a 'non-standardized allergenic extract.' While different manufacturers may produce the extract, they are not necessarily interchangeable because the exact concentration of proteins can vary between brands. In the supplement market, you may find various brands selling 'Prickly Ash Bark,' but these are not regulated for the treatment of allergies and should not be used as a substitute for clinical extracts. Always use the specific product provided or prescribed by your medical specialist to ensure consistency and safety.